Abstract
Bulimia nervosa (BN) and Anorexia Nervosa (AN) are currently classified as eating disorders (ED). Both disorders are the product of complex interaction between physiological and psychological and social processes; they are characterized by abnormal eating behavior. However, patients with BN differ from AN in their nutritional state and response of treatment with serotonin-selective reuptake inhibitor (SSRI) as well as frequency of comorbidity of mood and anxiety disorders. Although biological mechanisms of both BN and AN are largely unknown, excess of both feeding-stimulatory and feeding inhibitory signaling in AN have been indicated. This report reviews data that point to the hypothesis that dysregulation of monoaminergic and new peptidergic circuitry controlling food intake and energy expenditure play a major role in the eating behavior of BN.
Keywords: bulimia nervosa, eating disorder, monoamine, neuropeptide
Current Molecular Medicine
Title: Orexigenic / Anorexigenic Signals in Bulimia Nervosa
Volume: 3 Issue: 4
Author(s): Yoshiyuki Takimoto, Akio Inui, Hiroaki Kumano and Tomifusa Kuboki
Affiliation:
Keywords: bulimia nervosa, eating disorder, monoamine, neuropeptide
Abstract: Bulimia nervosa (BN) and Anorexia Nervosa (AN) are currently classified as eating disorders (ED). Both disorders are the product of complex interaction between physiological and psychological and social processes; they are characterized by abnormal eating behavior. However, patients with BN differ from AN in their nutritional state and response of treatment with serotonin-selective reuptake inhibitor (SSRI) as well as frequency of comorbidity of mood and anxiety disorders. Although biological mechanisms of both BN and AN are largely unknown, excess of both feeding-stimulatory and feeding inhibitory signaling in AN have been indicated. This report reviews data that point to the hypothesis that dysregulation of monoaminergic and new peptidergic circuitry controlling food intake and energy expenditure play a major role in the eating behavior of BN.
Export Options
About this article
Cite this article as:
Takimoto Yoshiyuki, Inui Akio, Kumano Hiroaki and Kuboki Tomifusa, Orexigenic / Anorexigenic Signals in Bulimia Nervosa, Current Molecular Medicine 2003; 3 (4) . https://dx.doi.org/10.2174/1566524033479762
DOI https://dx.doi.org/10.2174/1566524033479762 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The GABA A Receptor Subunits Heterologously Expressed in Xenopus Oocytes
Mini-Reviews in Medicinal Chemistry Acne Vulgaris: an Inflammatory Disease Even Before the Onset of Clinical Lesions
Inflammation & Allergy - Drug Targets (Discontinued) Serotonin and its Receptors in the Human CNS with New Findings - A Mini Review
Current Medicinal Chemistry NPY Y1 and Y5 Receptor Selective Antagonists as Anti-Obesity Drugs
Current Topics in Medicinal Chemistry Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes
Current Pharmaceutical Design Aspartame: Should Individuals with Type II Diabetes be Taking it?
Current Diabetes Reviews Melatonin and Aromatase in Breast Cancer
Clinical Cancer Drugs Steroids and Vasopressor-Resistant Hypotension in Preterm Infants
Current Pediatric Reviews Adipose Tissue in the Regulation of Inflammation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Effects of Physical Exercise on Inflammatory Markers of Atherosclerosis
Current Pharmaceutical Design Pharmacological and Biological Therapies for Metabolic Bone Disease in Critical Illness: An Integrative Physiology Approach
Current Drug Therapy Neuroimaging of Cancer Patients for Psychosocial Support and Patient Care
Current Medical Imaging The Neuroimmunoendocrine Network in the Complex Host-Parasite Relationship During Murine Cysticercosis
Current Topics in Medicinal Chemistry Growth Hormone Secretagogues
Combinatorial Chemistry & High Throughput Screening Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved
Current Neuropharmacology Current Challenges to Overcome in the Management of Type 2 Diabetes Mellitus and Associated Neurological Disorders
CNS & Neurological Disorders - Drug Targets Pathophysiology of Sepsis in the Elderly: Clinical Impact and Therapeutic Considerations
Current Drug Targets Ex Vivo Proton NMR Analysis and Characterization of Thymus Lipid Metabolites and their Variation with Age in C57BL/6 Mice
Current Aging Science Neural Pathways and Neuropeptides Mediate the Therapeutic Actions of DPP IV Inhibitors in Type-2 Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Is There a Role for Cytokine Based Therapies in Fibromyalgia
Current Pharmaceutical Design